ShareThis Page

McCandless woman's foundation offers Glimmer of Hope in battle against breast cancer

| Wednesday, Jan. 7, 2015, 9:00 p.m.
Deborah Deasy | Trib Total Media
Diana Napper is the founder of the Glimmer of Hope Foundation that donated $171,000 to buy the SenoClaire tomosynthesis machine for Allegheny Health Network.
Deborah Deasy | Trib Total Media
Diana Napper is the founder of the Glimmer of Hope Foundation that donated $171,000 to buy the SenoClaire tomosynthesis machine for Allegheny Health Network..
Diane Napper has raised $2.7 million for breast cancer research and patient services through annual benefits and sales of commissioned, costume jewelry featuring Swarovski crystals. People can currently buy the foundation’s Brace Yourself for Change bracelet for $65 to help purchase more 3-D breast imaging equipment.

Each week, about 50 women get mammograms in Pine on one of the first machines of its kind in the United States, thanks to a McCandless woman's determination to improve all women's odds of beating breast cancer.

“We're getting such rave reviews on this machine. … We need more of them,” said Diana Napper, 57, of McCandless, founder and executive director of the Glimmer of Hope Foundation.

Napper's nonprofit foundation donated $171,000 to buy the SenoClaire tomosynthesis unit and its work station for the Allegheny Health Network.

The machine, which can produce three-dimensional breast images, is available at the new Wexford Health & Wellness Pavilion in Pine.

In 1993, Napper, a mother of four, started the Glimmer of Hope Foundation after her best friend, Carol Friedman, formerly of New Jersey, died of breast cancer.

Since then, Napper has raised $2.7 million for breast-cancer research and patient services through annual benefits and sales of Glimmer of Hope costume jewelry.

Proceeds from the foundation's annual Dimond Family Golf Tournament in North Park and the Pitch for Hope, a yearly fundraiser organized with the Pittsburgh Pirates, helped to pay for the new 3-D breast imaging machine at the Wexford Health & Wellness Pavilion.

Using low-dose X-rays, the SenoClaire tomosynthesis unit can photograph nine layers of breast tissue, which helps physicians differentiate benign from dangerous abnormalities, and detect cancer in its earliest stages.

Allegheny Health Network got the 3-D imaging technology in October after the Federal Drug Administration approved the SenoClaire machine in September for use in the United States. GE Healthcare markets the machine.

“Allegheny Health Network was the first center in the nation to install a SenoClaire unit, GE Healthcare's new 3-D breast imaging tomosynthesis system,” said Ben Fox, spokesman for GE Healthcare.

For women getting a mammogram, the SenoClaire equipment feels the same as other mammogram machines, said mammography technologist Kimberly Lattanzio of Wexford Health & Wellness Pavilion.

“Most are shocked at how easy it is after it's over,” Lattanzio said.

Allegheny Health Network currently uses the SenoClaire tomosynthesis unit to test any woman with a strong family history of breast cancer, plus, women with very dense breast tissue and women whose earlier mammograms showed abnormalities.

“But if a patient wants 3-D (a three-dimensional mammogram), we will oblige that,” Lattanzio said.

Women should check with their insurance providers to see if they will be covered for the cost a three-dimensional mammogram.

Napper said she hopes to set up a fund to help women whose insurance companies might not cover the service.

Dr. William Poller, director of the breast-imaging division of the Allegheny Health Network, said he wanted the SenoClaire unit because of the increasing incidence of breast cancer in younger women and the machine's ability to identify abnormalities in younger women's dense breast tissue.

Poller hopes to acquire more SenoClaire tomosynthesis units for other Allegheny Health Network sites, including Allegheny General Hospital, West Penn Hospital, Forbes Hospital and Allegheny Valley Hospital.

Napper's Glimmer of Hope Foundation supports breast-cancer research and programs for breast-cancer patients at multiple Pittsburgh-area hospitals, including Magee-Womens Hospital — which also offers 3-D breast imaging — and the UPMC Hillman Cancer Center.

Deborah Deasy is a staff writer for Trib Total Media. She can be reached at 724-772-6369. or

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.